Federal Oversight of Orthopedic Device Companies Ends

The U.S. Attorney’s office office has ended 18 months of federal oversight of orthopedic device manufacturers Zimmer, Depuy Orthopaedics, Biomet Orthopedics, Stryker and Smith & Nephew, according to a report by the Star-Ledger.

Advertisement

The U.S. Attorney’s office charged the companies with violating federal anti-kickback statutes in 2007. The companies avoided prosecution by agreeing to strict compliance procedures and federal monitoring.

Zimmer, Depuy, Biomet and Smith & Nephew remain subject to the terms of separate agreements entered into with the Office of Inspector General of the Department of Health and Human Services until 2012.

Read the Star-Ledger‘s report on the end of federal oversight for orthopedic device companies.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedics

Advertisement

Comments are closed.